Litcius/Paper detail

REMOVED: Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy

Aruna Sharma, Dafin F. Mureșanu, Ranjana Patnaik, Preeti K. Menon, Z. Ryan Tian, Seaab Sahib, Ala Nozari, Ala Nozari, José Vicente Lafuente, Anca Dana Buzoianu, Stephen D. Skaper, Igor Bryukhovetskiy, Igor Manzhulo, Lars Wiklund

2021Progress in brain research26 citationsDOI

Topics & Concepts

HistaminergicHistamine H3 receptorPars compactaSubstantia nigraHistamineThioperamideAgonistNeuroprotectionHistamine receptorPharmacologyInternal medicineMedicineEndocrinologyNeuroscienceReceptorDopaminergicPsychologyAntagonistDopamineMast cells and histamineOlfactory and Sensory Function StudiesReceptor Mechanisms and Signaling
REMOVED: Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy | Litcius